Kendall Capital Management’s GSK GSK Stock Holding History

Kendall Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.42M	Buy	43,766 +1,810	+4%	+$98.1K	0.5%	54
2025 Q4	$2.06M	Buy	41,956 +9,015	+27%	+$420K	0.43%	58
2025 Q3	$1.42M	Buy	32,941 +7,495	+29%	+$293K	0.32%	72
2025 Q2	$977K	Buy	25,446 +11,050	+77%	+$422K	0.26%	100
2025 Q1	$558K	Buy	+14,396	New	+$527K	0.16%	140

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Kendall Capital Management's GSK Position: Q1 2026 in Review

Kendall Capital Management increased its GSK (GSK) stake by 4.3% in Q1 2026, buying an estimated $98.1K and bringing the position to 43,766 shares worth $2.42M. The position accounts for 0.5% of the portfolio, ranked #54.

Kendall Capital Management first reported a position in GSK in Q1 2025 and has held it in 5 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Kendall Capital Management held 43,766 shares of GSK worth $2.42M as of Q1 2026.
Kendall Capital Management bought 1,810 GSK shares in Q1 2026, an estimated $98.1K.
GSK made up 0.5% of Kendall Capital Management's portfolio in Q1 2026, its #54 holding.
Kendall Capital Management first reported a position in GSK in Q1 2025 and has held it in 5 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Kendall Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.